1. | ivreb777 | |
2. | GoldTrader | |
3. | jshjohwalla | |
4. | ray66695 | |
5. | t66860 |
1. | ivreb777 | |
2. | GoldTrader | |
3. | jshjohwalla | |
4. | ray66695 | |
5. | t66860 |
1. | GoldTrader 03/19/2018 Viveve Announces FDA Approval of IDE to Conduct VIVEVE II Clinical Study |
2. | GoldTrader 01/31/2018 Viveve Announces Expansion of CMRF Technology Platform into Stress Urinary Incontinence Market |
3. | jshjohwalla 02/08/2018 Announces pricing of 10 mln shares of common stock at $3.00/share |
4. | ivreb777 02/27/2018 Viveve to Present at March Investor Conferences |
5. | ivreb777 03/15/2018 Misses EPS loss estimates by $0.07 |
6. | ivreb777 02/07/2018 Commenced an underwritten public offering of shares of its common stock |